Jumpcan Pharmaceutical Group
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Jumpcan Pharmaceutical Group
Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology
French pharma makes $180m equity investment in Owkin under collaboration targeting four cancer types. Pyramid gets global license to MPS1 precision cancer candidate from Voronoi.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.